Filing metadata

Accession number
0001140361-22-009984
Form type
Form 4
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Mar 17, 2022
Reporting period
Mar 11, 2022
Description
Insider transaction

Explore SEC Filings Hub